A detailed history of Cowen Prime Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cowen Prime Advisors LLC holds 3,000 shares of NVO stock, worth $262,110. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,000
Previous 3,000 -0.0%
Holding current value
$262,110
Previous $501,000 3.19%
% of portfolio
0.17%
Previous 0.2%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$132.34 - $159.14 $33,085 - $39,785
-250 Reduced 7.69%
3,000 $501,000
Q2 2020

Aug 01, 2022

BUY
$58.54 - $67.94 $190,255 - $220,805
3,250 New
3,250 $362,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cowen Prime Advisors LLC Portfolio

Follow Cowen Prime Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen Prime Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen Prime Advisors LLC with notifications on news.